WNK2 and cancer: The crosstalk of FADD with cancer-related signaling pathways, such as mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) signaling pathways, is considered a main mechanism through which FADD participates in the modulation of cancer progression.